Akebia Therapeutics (AKBA) Announces CFO Transition
Tweet
Share
E-mailGet Alerts AKBA Hot Sheet
Join SI Premium – FREE
On March 15, 2024, Akebia Therapeutics (NASDAQ: AKBA) and Ellen Snow mutually agreed that she would transition from her role as the Company’s Senior Vice President, Chief Financial Officer and Treasurer, effective March 22, 2024 (the “Transition Date”).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Revolution Medicines prices RASONQUE at $39,800 per month
- American Resources gets second Nasdaq notice for late SEC filing
- KKR & Co. (KKR) To Pay $250 Million To Resolve Doj Merger Filing Lawsuit - Bloomberg
Create E-mail Alert Related Categories
8K, Corporate News, Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
